GENEREUX SCOTT 4
4 · ROCKWELL AUTOMATION, INC · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Rockwell Automation (ROK) Sr. VP Scott Genereux Exercises Options, Sells Shares
What Happened
- Scott Genereux, Senior Vice President and Chief Revenue Officer at Rockwell Automation (ROK), exercised stock options and sold shares on 2026-02-25. He exercised two option awards totaling 16,207 shares (6,844 shares at $350.76 and 9,363 shares at $259.81), paying about $4,833,202 in aggregate.
- He sold a series of open-market lots totaling 17,407 shares on the same date, generating approximately $7,043,126 in proceeds (sales executed at weighted-average prices in the $401.67–$409.37 range as detailed in the filing).
Key Details
- Transaction date: February 25, 2026; Form 4 filed February 27, 2026 (timely).
- Option exercises: 6,844 shares @ $350.76 ($2,400,601) and 9,363 shares @ $259.81 ($2,432,601).
- Open-market sales: 17,407 shares across multiple trades; total proceeds ≈ $7,043,126 (weighted average prices reported; see footnotes for exact price ranges).
- Additional reporting items: two derivative-disposition lines show the exercised options as disposed at $0 (these reflect the conversion/settlement of the derivative instrument).
- Footnotes: sales and some post-exercise transactions were executed pursuant to a Rule 10b5-1 plan established 11/26/2025; multiple footnotes report weighted-average prices and price ranges for each sales block.
- Shares owned after the transactions are not specified in the provided excerpt of the Form 4.
Context
- This was an exercise of options (derivative code M) followed by open-market sales (code S). Because the exercises and sales occurred the same day and some sales were executed under a 10b5-1 plan, this resembles a routine lockup/monetization transaction rather than a fresh open-market purchase.
- For retail investors: exercises plus immediate or planned sales are common for executives to cover exercise costs, taxes, or diversify—such transactions are informational but don't by themselves indicate a change in company outlook.
Insider Transaction Report
Form 4
GENEREUX SCOTT
Sr.VP, Chief Revenue Officer
Transactions
- Exercise/Conversion
Common Stock
2026-02-25$350.76/sh+6,844$2,400,601→ 11,358 total - Exercise/Conversion
Common Stock
2026-02-25$259.81/sh+9,363$2,432,601→ 20,721 total - Sale
Common Stock
[F1][F2]2026-02-25$402.16/sh−2,942$1,183,145→ 17,779 total - Sale
Common Stock
[F1][F3]2026-02-25$403.10/sh−2,584$1,041,616→ 15,195 total - Sale
Common Stock
[F1][F4]2026-02-25$404.24/sh−4,861$1,965,029→ 10,334 total - Sale
Common Stock
[F1][F5]2026-02-25$405.47/sh−3,899$1,580,943→ 6,435 total - Sale
Common Stock
[F1][F6]2026-02-25$406.42/sh−1,381$561,269→ 5,054 total - Sale
Common Stock
[F1][F7]2026-02-25$407.04/sh−460$187,240→ 4,594 total - Sale
Common Stock
[F1]2026-02-25$408.00/sh−80$32,640→ 4,514 total - Sale
Common Stock
[F8]2026-02-25$409.37/sh−1,200$491,244→ 3,314 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F9]2026-02-25−6,844→ 0 totalExercise: $350.76From: 2022-12-07Exp: 2031-12-07→ Common Stock (6,844 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F9]2026-02-25−9,363→ 300 totalExercise: $259.81From: 2023-12-09Exp: 2032-12-09→ Common Stock (9,363 underlying)
Footnotes (9)
- [F1]Shares exercised and sold pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
- [F2]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $401.6650 to $402.60. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $402.70 to $403.6850. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F4]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $403.7750 to $404.77. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F5]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $404.8250 to $405.7550. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F6]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $405.86 to $406.84. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F7]Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $406.8650 to $407.66. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
- [F8]Sale of shares pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
- [F9]The option vests in three substantially equal annual installments beginning on the date exercisable.
Signature
Danielle White, Attorney-in-fact for Scott Genereux|2026-02-27